Splicing variants of a human hemopoietin receptor gene NR10 are successfully isolated by PCR cloning. The protein encoded by the isolated genes occurs in two types, i.e., a transmembrane type and a soluble type. The expression of the gene encoding the transmembrane protein is found out in ...
The inventors succeeded in isolating a novel hemopoietin receptor gene (NR10) using a sequence predicted from the extracted motif conserved in the amino acid sequences of known hemopoietin receptors.
Community Home Storage Midrange and Enterprise Storage StoreVirtual Storage Re: Multisite SV3200 Cluster with NR10 and NR0 1814727Members 4125Online 109548Solutions Forums Blogs Information Community Language New Discussion Log In SOLVED Johannes_we ...
掌桥科研 FreePatentsOnline 相似文献 参考文献Abstract P1-11-10: Reversible versus irreversible tyrosine kinase inhibitors (TKIs) combined with antibody-drug conjugates (ADCs) in HER2-positive (HER2+) ... The anti-proliferative effects of afatinib, lapatinib, neratinib and tucatinib; of T-DM1 and T...
The present inventors successfully obtained anti-NR10 antibodies having an effective neutralizing activity against NR10. The anti-NR10 antibodies provided by the present invention are useful as, for example, pharmaceuticals for treating or preventing inflammatory diseases.Taichi Kuramochi...
In addition, the present inventors successfully obtained an anti-human NR 10 neutralizing antibody, providing extremely useful therapeutic agents with practical clinical applications.Masakazu HasegawaHidetomo KitamuraHideki AdachiKeiko Kasutani
Novel hemopoietin receptor protein ,nr10A novel hemopoietin receptor gene (NR10) is successfully isolated based on a sequence anticipated by extracting a conserved motif from the amino acid sequence of a known hemopoietin receptor. It is considered that NR10 occurs as a transmembrane protein...
ANTI-NR10 ANTIBODY AND USE THEREOFAn anti-NR10 antibody having an effective neutralizing activity on NR10 is successfullyproduced. The anti-NR10 antibody is useful, for example, as a pharmaceuticalagent for the treatment or prevention of inflammatory diseases.KURAMOCHI, Taichi...
Anti-NR10 antibodies having an effective neutralizing activity on NR10 have been successfully acquired. These anti-NR10 antibodies thus provided are useful as drugs for treating or preventing, for example, inflammatory diseases.doi:WO2010064456 A1KURAMOCHI, Taichi...
The present inventors successfully obtained anti-NR10 antibodies having an effective neutralizing activity against NR10. The anti-NR10 antibodies provided by the present invention are useful as, for example, pharmaceuticals for treating or preventing inflammatory diseases....